COMMUNIQUÉS West-GlobeNewswire

Nova Leap Health Corp. announces Closing of Strategic Acquisition in Nova Scotia
01/05/2026
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 01, 2026 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
InflaRx to Report First Quarter 2026 Results on May 7, 2026
01/05/2026
JENA, Germany, May 01, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company [...]
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
01/05/2026
NEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, will host a virtual investor [...]
Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting
01/05/2026
BASEL, Switzerland and BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Noema Pharma AG today announced the presentation of Phase 2a study results evaluating cendifensine in menopausal women experiencing moderate-to-severe [...]
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results
01/05/2026
Enrollment completed in ML-007C-MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorder Topline results from both Phase 2 trials expected by [...]
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
01/05/2026
SEATTLE and CAMBRIDGE, United Kingdom, May 01, 2026 (GLOBE NEWSWIRE) -- Pluristyx, a leading provider of clinical-grade induced pluripotent stem cell (iPSC) solutions, and Qkine, a pioneer in the manufacture of high- [...]
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity
01/05/2026
-- First therapy to be FDA-approved and EC-authorized for acquired hypothalamic obesity -- -- European Commission grants authorization in adults and children 4 years of age and above with acquired hypothalamic obesity [...]
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
01/05/2026
HEMANGEOL is now available exclusively through Anovo Specialty Pharmacy to streamline access and therapy initiation Eton has integrated full Eton Cares patient support, including $0 co-pay for eligible commercially [...]
BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
01/05/2026
LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex [...]
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
01/05/2026
Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive therapeutic options to be presented by Baruch Kuppermann, M.D., Ph.D. New [...]
Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
01/05/2026
ZUG, Switzerland, May 01, 2026 (GLOBE NEWSWIRE) -- Latest findings from the DME AWARE Delphi Study on unmet needs in diabetic macular edema (DME) management highlighting the need for non-invasive therapeutic options to [...]
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026
01/05/2026
Tokyo, Japan and Cambridge, UK, 1 May 202 6 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March [...]
MemoPryl Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
01/05/2026
MemoPryl Scam Warning Explained: Nootropic Ingredients, Official Website Pricing, and 60-Day Refund Policy — 2026 Consumer Verification Update Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not [...]
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
01/05/2026
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable [...]
SteelPower Capsules for Male Enhancement Support: Review the Ingredients & Where to Buy to Avoid Complaints
01/05/2026
SteelPower Ingredient Label, Pricing, and Official Availability Explained for Men Researching Male Performance Support Supplements Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated [...]
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
01/05/2026
AUSTIN, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics, Inc. ("Rein" or the "Company") (NASDAQ: RNTX), a clinical-stage biopharmaceutical company advancing a novel pipeline of first-in-class medicines for [...]
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
01/05/2026
NEW YORK & TORONTO, April 30, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on April 28, 2026, by Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP), please note references to Veterans Exploring [...]
Leanzene Gummies Under Investigation (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks
01/05/2026
Leanzene Gummies Scam Warning Explained: ACV and BHB Ingredients, Official Website Pricing, and 60-Day Money-Back Policy — 2026 Update Aurora, CO, April 30, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
01/05/2026
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, April 30, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of [...]

Pages